| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADAM-17 predicts adverse outcome in patients with breast cancer
|
McGowan, P.M.
|
|
|
19 |
6 |
p. 1075-1081
|
artikel
|
| 2 |
Adjuvant low-dose interferon α2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis
|
Garbe, C.
|
|
|
19 |
6 |
p. 1195-1201
|
artikel
|
| 3 |
A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes
|
Yada, A.
|
|
|
19 |
6 |
p. 1060-1067
|
artikel
|
| 4 |
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer
|
Burstein, H.J.
|
|
|
19 |
6 |
p. 1068-1074
|
artikel
|
| 5 |
A rationale for starting breast cancer screening under age 50
|
van Schoor, G.
|
|
|
19 |
6 |
p. 1208-1209
|
artikel
|
| 6 |
Biweekly cetuximab and irinotecan as third-line therapy in patients with advanced colorectal cancer after failure to irinotecan, oxaliplatin and 5-fluorouracil
|
Pfeiffer, P.
|
|
|
19 |
6 |
p. 1141-1145
|
artikel
|
| 7 |
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
|
Palumbo, A.
|
|
|
19 |
6 |
p. 1160-1165
|
artikel
|
| 8 |
Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials
|
Yang, S.H.
|
|
|
19 |
6 |
p. 1039-1044
|
artikel
|
| 9 |
Chronomodulated capecitabine in combination with short-time oxaliplatin: a Nordic phase II study of second-line therapy in patients with metastatic colorectal cancer after failure to irinotecan and 5-flourouracil
|
Qvortrup, C.
|
|
|
19 |
6 |
p. 1154-1159
|
artikel
|
| 10 |
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study
|
Belkacémi, Y.
|
|
|
19 |
6 |
p. 1110-1116
|
artikel
|
| 11 |
COX-2 targeting in cancer: a new beginning?
|
Milella, M.
|
|
|
19 |
6 |
p. 1209-1210
|
artikel
|
| 12 |
Editorial board
|
|
|
|
19 |
6 |
p. ii-iii
|
artikel
|
| 13 |
EGFR regulation by microRNA in lung cancer: a rose by any other name … is an increasingly complicated rose
|
Hayes, D.N.
|
|
|
19 |
6 |
p. 1036-1037
|
artikel
|
| 14 |
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
|
Weiss, G.J.
|
|
|
19 |
6 |
p. 1053-1059
|
artikel
|
| 15 |
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
|
Untch, M.
|
|
|
19 |
6 |
p. 1090-1096
|
artikel
|
| 16 |
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age
|
Hosing, C.
|
|
|
19 |
6 |
p. 1166-1171
|
artikel
|
| 17 |
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?
|
Harputluoglu, H.
|
|
|
19 |
6 |
p. 1203
|
artikel
|
| 18 |
Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)
|
Abdalla, A.O.
|
|
|
19 |
6 |
p. 1172-1179
|
artikel
|
| 19 |
In this issue
|
|
|
|
19 |
6 |
p. 1031
|
artikel
|
| 20 |
ISO 9001:2000 applied to a research oncology laboratory: which problems? The experience of National Cancer Institute-Bari
|
Lacalamita, R.
|
|
|
19 |
6 |
p. 1207-1208
|
artikel
|
| 21 |
Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients
|
van Iersel, L.B.J.
|
|
|
19 |
6 |
p. 1127-1134
|
artikel
|
| 22 |
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb®) in human breast carcinoma cells
|
Vazquez-Martin, A.
|
|
|
19 |
6 |
p. 1097-1109
|
artikel
|
| 23 |
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
|
Jeong, J.
|
|
|
19 |
6 |
p. 1135-1140
|
artikel
|
| 24 |
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials
|
Collette, S.
|
|
|
19 |
6 |
p. 1117-1126
|
artikel
|
| 25 |
Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura
|
Spoormans, I.
|
|
|
19 |
6 |
p. 1204-1207
|
artikel
|
| 26 |
Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations
|
Héry, C.
|
|
|
19 |
6 |
p. 1187-1194
|
artikel
|
| 27 |
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up
|
Zander, A.R.
|
|
|
19 |
6 |
p. 1082-1089
|
artikel
|
| 28 |
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
|
Cheon, S.H.
|
|
|
19 |
6 |
p. 1146-1153
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
19 |
6 |
p. iv-v
|
artikel
|
| 30 |
The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003)
|
Chen, M.-C.
|
|
|
19 |
6 |
p. 1180-1186
|
artikel
|
| 31 |
The perspective and role of the medical oncologist in cancer prevention: A position paper by the European Society for Medical Oncology
|
Baselga, J.
|
|
|
19 |
6 |
p. 1033-1035
|
artikel
|
| 32 |
The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism
|
Beckers, M.M.J.
|
|
|
19 |
6 |
p. 1203-1204
|
artikel
|
| 33 |
The role of UFT in advanced gastric cancer
|
Aykan, N.F.
|
|
|
19 |
6 |
p. 1045-1052
|
artikel
|
Tijdschrift beschrijving